SI-BONE INC

SI‑BONE insider buy: Jeryl H. Hilleman snaps up 10,957 shares amid a 33% rally, signaling confidence in the company’s clinical pipeline and governance strength.

Explore SI‑Bone’s insider sell‑to‑cover activity, its tax‑cover rationale, and market sentiment—insights for investors on short‑term impact and long‑term upside.

Insider RSU activity at SI‑BONE shows tax‑hedging and confident buying—signaling management’s belief in a future earnings turnaround and product launch momentum.

Discover why SI‑BONE’s insider sell‑to‑cover on Feb 2 is mainly tax‑cover, not a bearish signal, and what Q4 earnings mean for investors.